ÖGP 2021: Meta-analysis on the specificity of microbiome-based signatures for predicting immune checkpoint inhibitor therapy response in non-small cell lung cancer patients
ready to TALK MICROBIOME?
Reach out to our team with any questions about BiomeDx. We're here to support your understanding of our platform and services.